Cardiac deletion of Smyd2 is dispensable for mouse heart development.
Chromatin modifying enzymes play a critical role in cardiac differentiation. Previously, it has been shown that the targeted deletion of the histone methyltransferase, Smyd1, the founding member of the SET and MYND domain containing (Smyd) family, interferes with cardiomyocyte maturation and proper...
Main Authors: | Florian Diehl, Mark A Brown, Machteld J van Amerongen, Tatyana Novoyatleva, Astrid Wietelmann, June Harriss, Fulvia Ferrazzi, Thomas Böttger, Richard P Harvey, Philip W Tucker, Felix B Engel |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-03-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20305823/pdf/?tool=EBI |
Similar Items
-
Structural and functional profiling of the human histone methyltransferase SMYD3.
by: Kenneth W Foreman, et al.
Published: (2011-01-01) -
Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation.
by: Michael J Thomenius, et al.
Published: (2018-01-01) -
Functional characterization of the split SET and MYND domain-containing methyltransferases, Smyd2 & Smyd3
by: Brown, Mark Alan, 1975-
Published: (2008) -
Smyd1 facilitates heart development by antagonizing oxidative and ER stress responses.
by: Tara L Rasmussen, et al.
Published: (2015-01-01) -
The SMYD1 and skNAC transcription factors contribute to neurodegenerative diseases
by: R. Dayne Mayfield, et al.
Published: (2020-12-01)